Ethema Health(GRST)
$0.000.00 (0.00%)
GRST
Ethema Health financials statements
$0.00
At close:0.00 (0.00%)
Ethema Health (GRST) Ratios
13 Followers
Ethema Health Ratios
GRST's free cash flow for Q4 2025 was $187.24K. For the 2025 fiscal year, GRST's free cash flow was decreased by $-119.02K and operating cash flow was $306.26K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.10 | 0.05 | 0.05 | 0.04 | 0.02 |
| Quick Ratio | 0.10 | 0.05 | 0.05 | 0.04 | 0.02 |
| Cash Ratio | 0.00 | 0.03 | 0.01 | 0.01 | 0.00 |
| Solvency Ratio | -0.01 | -0.07 | 0.10 | 0.07 | -0.07 |
| Operating Cash Flow Ratio | -0.00 | -0.05 | -0.06 | 0.12 | -0.01 |
| Short-Term Operating Cash Flow Coverage | -0.01 | -0.07 | -0.10 | 0.17 | -0.01 |
| Net Current Asset Value | $ -36.85M | $ -19.09M | $ -17.32M | $ -14.85M | $ -15.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.82 | 1.42 | 1.27 | 1.74 | 1.76 |
| Debt-to-Equity Ratio | -2.46 | -2.31 | -2.35 | -1.18 | -1.12 |
| Debt-to-Capital Ratio | 1.69 | 1.76 | 1.74 | 6.61 | 9.38 |
| Long-Term Debt-to-Capital Ratio | 2.08 | -0.00 | -0.00 | -0.07 | -0.07 |
| Financial Leverage Ratio | -2.99 | -1.63 | -1.86 | -0.68 | -0.64 |
| Debt Service Coverage Ratio | 0.49 | -0.07 | 0.42 | 0.22 | 0.14 |
| Interest Coverage Ratio | 0.00 | -1.36 | -0.69 | 0.40 | 0.00 |
| Debt to Market Cap | 6.13 | 1.38 | 4.59 | 6.69 | 3.60 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | 12.90 | -29.82 | 7.01 | 4.66 | 8.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 87.35% | 75.96% | 90.79% |
| EBIT Margin | 0.00% | -19.68% | 26.12% | 33.62% | 48.42% |
| EBITDA Margin | 9.75% | -9.47% | 38.77% | 50.22% | 71.28% |
| Operating Profit Margin | 0.00% | -22.15% | -10.14% | 10.15% | 0.11% |
| Pretax Profit Margin | -11.89% | -36.00% | 11.50% | 8.45% | -95.42% |
| Net Profit Margin | -11.89% | -34.30% | 22.02% | 5.14% | -79.41% |
| Continuous Operations Profit Margin | 0.00% | -36.00% | 18.82% | 6.12% | -80.96% |
| Net Income Per EBT | 100.00% | 95.29% | 191.55% | 60.84% | 83.23% |
| EBT Per EBIT | 0.00% | 162.49% | -113.37% | 83.29% | -88076.01% |
| Return on Assets (ROA) | -7.75% | -16.98% | 10.22% | 3.78% | -23.54% |
| Return on Equity (ROE) | 23.15% | 27.67% | -18.98% | -2.55% | 15.01% |
| Return on Capital Employed (ROCE) | 0.00% | -53.24% | -16.83% | -7.27% | -0.03% |
| Return on Invested Capital (ROIC) | 0.00% | -13.63% | -6.47% | 12.57% | 0.08% |
| Return on Tangible Assets | -9.97% | -17.76% | 11.08% | 4.67% | -31.21% |
| Earnings Yield | -57.73% | -40.91% | 105.21% | 16.73% | -57.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.97 | 23.07 | 17.06 | 14.30 | 11.04 |
| Payables Turnover | 0.00 | 0.80 | 1.92 | 6.78 | 0.41 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 25.91 | 6.01 |
| Fixed Asset Turnover | 0.92 | 0.57 | 0.54 | 1.10 | 0.42 |
| Asset Turnover | 0.65 | 0.49 | 0.46 | 0.73 | 0.30 |
| Working Capital Turnover Ratio | -1.64 | -0.71 | -0.52 | -0.37 | -0.15 |
| Cash Conversion Cycle | 28.13 | -438.25 | -168.68 | -14.23 | -801.92 |
| Days of Sales Outstanding | 28.13 | 15.82 | 21.40 | 25.52 | 33.06 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 14.08 | 60.73 |
| Days of Payables Outstanding | 0.00 | 454.07 | 190.07 | 53.84 | 895.72 |
| Operating Cycle | 28.13 | 15.82 | 21.40 | 39.60 | 93.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -0.12 | -1.52 | -13.06 | 4.99 | -0.55 |
| Capital Expenditure Coverage Ratio | -0.12 | -1.52 | -13.06 | 4.99 | -0.64 |
| Operating Cash Flow Coverage Ratio | -0.00 | -0.03 | -0.04 | 0.14 | -0.01 |
| Operating Cash Flow to Sales Ratio | -0.00 | -0.08 | -0.10 | 0.33 | -0.04 |
| Free Cash Flow Yield | -8.04% | -14.98% | -51.02% | 85.11% | -8.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.73 | -2.33 | 0.95 | 5.98 | -1.75 |
| Price-to-Sales (P/S) Ratio | 0.21 | 0.84 | 0.21 | 0.31 | 1.39 |
| Price-to-Book (P/B) Ratio | -0.40 | -0.68 | -0.18 | -0.15 | -0.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.44 | -6.67 | -1.96 | 1.17 | -12.37 |
| Price-to-Operating Cash Flow Ratio | -117.51 | -11.07 | -2.11 | 0.94 | -31.57 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 0.00 | -0.05 | 0.01 |
| Enterprise Value Multiple | 15.02 | -38.67 | 7.55 | 5.28 | 10.22 |
| Enterprise Value | 27.47M | 22.04M | 15.63M | 12.77M | 14.16M |
| EV to EBITDA | 15.02 | -38.67 | 7.55 | 5.28 | 10.22 |
| EV to Sales | 1.46 | 3.66 | 2.92 | 2.65 | 7.29 |
| EV to Free Cash Flow | -88.44 | -29.15 | -27.39 | 10.13 | -64.82 |
| EV to Operating Cash Flow | -835.62 | -48.36 | -29.49 | 8.10 | -165.45 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.64 | 0.28 | 0.15 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
| Tax Burden | 1.00 | 0.95 | 1.92 | 0.61 | 0.83 |
| Interest Burden | 0.00 | 1.83 | 0.44 | 0.25 | -1.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.29 | 1.14 | 0.94 | 0.79 | 0.83 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.02 | 0.21 | -0.45 | 5.34 | 0.06 |
Currency in USD
